ES2004543A6 - Procedimiento para la preparacion de clatratos con ciclodextrinas de derivados de carbaciclina - Google Patents

Procedimiento para la preparacion de clatratos con ciclodextrinas de derivados de carbaciclina

Info

Publication number
ES2004543A6
ES2004543A6 ES8700629A ES8700629A ES2004543A6 ES 2004543 A6 ES2004543 A6 ES 2004543A6 ES 8700629 A ES8700629 A ES 8700629A ES 8700629 A ES8700629 A ES 8700629A ES 2004543 A6 ES2004543 A6 ES 2004543A6
Authority
ES
Spain
Prior art keywords
group
carbon atoms
hydrogen
alkyl
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700629A
Other languages
English (en)
Inventor
Werner Skuballa
Helmut Vorbruggen
Helmut Dahl
Claus-Steffen Sturzebecher
Karl-Heinz Thierauch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES2004543A6 publication Critical patent/ES2004543A6/es
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Abstract

EL PROCEDIMIENTO PARA LA OBTENCION DE LOS COMPUESTOS DE FORMULAEN DONDE R1, A, W, D, M, E, R2, R3, N Y X TIENEN LOS SIGNIFICADOS INDICADOS EN LA DESCRIPCION, SE CARACTERIZA PORQUE LOS COMPUESTOS ANALOGOS DE CARBACICLINA DE FORMULA I O SUS SALES SODICAS, CUANDO R1 EN LA FORMULA I SIGNIFICA HIDROGENO SE DISUELVEN EN UN ALCOHOL, UNA CETONA O UN ETER FORMACOLOGICAMENTE INOCUOS, Y SE HACEN REACCIONAR CON SOLUCIONES ACUOSAS DE A-, A- O Y19G- CICLODEXTRINA 20-80G. LOS COMPUESTOS OBTENIDOS TIENEN SU APLICACION COMO MEDICAMENTOS.
ES8700629A 1986-03-07 1987-03-07 Procedimiento para la preparacion de clatratos con ciclodextrinas de derivados de carbaciclina Expired ES2004543A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3608088A DE3608088C2 (de) 1986-03-07 1986-03-07 Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten

Publications (1)

Publication Number Publication Date
ES2004543A6 true ES2004543A6 (es) 1989-01-16

Family

ID=6296073

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700629A Expired ES2004543A6 (es) 1986-03-07 1987-03-07 Procedimiento para la preparacion de clatratos con ciclodextrinas de derivados de carbaciclina

Country Status (22)

Country Link
US (1) US4886788A (es)
EP (1) EP0259468B1 (es)
JP (2) JPH07107020B2 (es)
AT (1) AT397084B (es)
AU (2) AU6988687A (es)
CA (1) CA1309087C (es)
CH (1) CH672313A5 (es)
CS (1) CS270558B2 (es)
DD (1) DD258942A5 (es)
DE (3) DE3608088C2 (es)
ES (1) ES2004543A6 (es)
FI (1) FI92388C (es)
GB (2) GB2189783A (es)
GR (1) GR870363B (es)
HU (1) HU198906B (es)
IE (1) IE59760B1 (es)
IL (1) IL81802A (es)
NO (1) NO173440C (es)
NZ (1) NZ219508A (es)
SU (1) SU1632371A3 (es)
WO (1) WO1987005294A1 (es)
ZA (1) ZA871663B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663316A (en) * 1985-06-28 1987-05-05 Warner-Lambert Company Antibiotic clathrates and pharmaceutical compositions thereof
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
EP0410652B1 (en) * 1989-07-27 1995-05-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion
DE3933523A1 (de) * 1989-10-05 1991-04-11 Schering Ag Antimetastatisch wirkende mittel
DE4010355A1 (de) * 1990-03-28 1991-10-02 Schering Ag Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE4104606C1 (es) * 1991-02-12 1992-10-15 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US5221735A (en) * 1991-02-25 1993-06-22 Hoffmann-La Roche Inc. Cyclodextrin-polyene inclusion complexes
DE4135193C1 (es) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US6103403A (en) * 1997-05-15 2000-08-15 University Of Kentucky Research Foundation Intellectual Property Development Clathrate structure for electronic and electro-optic applications
DE19808634A1 (de) 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
DE19828881A1 (de) * 1998-06-22 1999-12-23 Schering Ag Oxidationsinhibitor bei Prostan-Derivaten
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
MY158766A (en) * 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
MY145694A (en) * 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
TW200730474A (en) 2005-12-29 2007-08-16 Schering Ag Diamine derivatives as inhibitors of leukotriene A4 hydrolease
JPWO2008018592A1 (ja) * 2006-08-11 2010-01-07 大正製薬株式会社 プロスタグランジン誘導体含有外用剤
AU2007319580B2 (en) 2006-10-12 2012-11-29 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
JP2010506853A (ja) * 2006-10-12 2010-03-04 ゼノン・ファーマシューティカルズ・インコーポレイテッド 疼痛などのナトリウムチャネル媒介性の疾患の処置のための、スピロ（［３，２−フロ］ピリジン−３，３’−インドール）−２’（１’ｈ）−オン誘導体および関連化合物
CN103664973B (zh) * 2008-10-17 2017-04-19 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
EP2350091B1 (en) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) * 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
WO2011047173A2 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
MY179342A (en) * 2009-10-14 2020-11-04 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
EP3266444A1 (en) 2010-02-26 2018-01-10 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
KR20150002794A (ko) 2012-04-12 2015-01-07 제논 파마슈티칼스 인크. 치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성
BR112015022226A2 (pt) 2013-03-14 2017-07-18 Celtaxsys Inc inibidores de leucotrieno a4 hidrolase
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
WO2017218920A1 (en) 2016-06-16 2017-12-21 Teva Pharmaceuticals International Gmbh Asymmetric synthesis of funapide
WO2018107158A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase
EP3551608A1 (en) 2016-12-09 2019-10-16 Celtaxsys Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase
KR20190088551A (ko) 2016-12-09 2019-07-26 켈탁시스, 인코퍼레이티드 루코트리엔 a4 하이드롤라제의 저해제
HU231212B1 (hu) * 2018-04-16 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás iloprost előállítására
RU2741848C1 (ru) * 2019-03-16 2021-01-29 Иванова Мария Ивановна Способ получения клатратных комплексов летучих веществ
WO2023037934A1 (ja) * 2021-09-13 2023-03-16 富士フイルム株式会社 ビシクロアルカン化合物の包摂体の製造方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (es) * 1970-06-10 1975-02-04
AU476695B2 (en) * 1974-01-15 1975-07-17 Ono Pharmaceutical Co. Ltd Clathrate prostaglandins and compositions containing same
HU179141B (es) * 1977-09-23 1982-08-28
DE2912409A1 (de) * 1978-03-31 1979-10-11 Ono Pharmaceutical Co 6,9-methano-pgi tief 2 -analoge
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS56150039A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Clathrate compound of prostacycline derivative
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS5818357A (ja) * 1981-07-28 1983-02-02 Ono Pharmaceut Co Ltd ６，９−メタノ−ｐｇｉ↓２及び６，９−メタノ−ｐｇｉ↓２類似化合物の安定化組成物及びその製造方法
JPS58116423A (ja) * 1981-12-28 1983-07-11 Sumitomo Chem Co Ltd メタノプロスタサイクリン製剤組成物
JPS58192821A (ja) * 1982-04-30 1983-11-10 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患の治療剤
JPS58216140A (ja) * 1982-05-28 1983-12-15 メイ・アンド・ベイカ−・リミテツド 新規なプロスタグランジン類似体
JPS59141536A (ja) * 1983-02-01 1984-08-14 Sumitomo Chem Co Ltd 新規ビシクロオクタン誘導体
DE3306123A1 (de) * 1983-02-18 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
FR2547818B1 (fr) * 1983-05-24 1986-09-05 May & Baker Ltd Nouveaux analogues de prostaglandines, leur preparation, les compositions pharmaceutiques qui les contiennent et les intermediaires-cles pour les preparer
DE3405181A1 (de) * 1984-02-10 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0171992B1 (en) * 1984-08-09 1990-06-06 Mitsubishi Kasei Corporation Pharmaceuticals containing prostaglandin i2
JPS6144819A (ja) * 1984-08-09 1986-03-04 Sagami Chem Res Center プロスタグランジンｉ２類縁化合物を含有する循環改善作用を有する薬剤
JPS6216A (ja) * 1985-03-19 1987-01-06 Sankyo Co Ltd カルバサイクリン類及びこれを有効成分とする抗潰瘍剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten

Also Published As

Publication number Publication date
AT397084B (de) 1994-01-25
GB8704982D0 (en) 1987-04-08
AU7160987A (en) 1987-09-28
NO874632D0 (no) 1987-11-06
FI92388C (fi) 1994-11-10
FI92388B (fi) 1994-07-29
IL81802A (en) 1991-07-18
FI874406A (fi) 1987-10-07
DE3790121D2 (en) 1988-03-10
JP2634787B2 (ja) 1997-07-30
EP0259468A1 (de) 1988-03-16
FI874406A0 (fi) 1987-10-07
JPH08193046A (ja) 1996-07-30
WO1987005294A1 (en) 1987-09-11
SU1632371A3 (ru) 1991-02-28
CS270558B2 (en) 1990-07-12
NZ219508A (en) 1990-08-28
NO173440B (no) 1993-09-06
GR870363B (en) 1987-06-30
ATA900787A (de) 1993-06-15
JPS63502665A (ja) 1988-10-06
DD258942A5 (de) 1988-08-10
HUT45484A (en) 1988-07-28
US4886788A (en) 1989-12-12
NO173440C (no) 1993-12-15
GB2199031B (en) 1990-01-10
IE59760B1 (en) 1994-03-23
ZA871663B (en) 1987-08-28
GB2189783A (en) 1987-11-04
CA1309087C (en) 1992-10-20
CH672313A5 (es) 1989-11-15
GB2199031A (en) 1988-06-29
DE3770085D1 (de) 1991-06-20
IL81802A0 (en) 1987-10-20
EP0259468B1 (de) 1991-05-15
DE3608088A1 (de) 1987-09-10
DE3608088C2 (de) 1995-11-16
IE870586L (en) 1987-09-07
JPH07107020B2 (ja) 1995-11-15
AU609390B2 (en) 1991-05-02
CS151187A2 (en) 1989-11-14
GB8725695D0 (en) 1987-12-09
AU6988687A (en) 1987-09-10
NO874632L (no) 1987-11-06
HU198906B (en) 1989-12-28

Similar Documents

Publication Publication Date Title
ES2004543A6 (es) Procedimiento para la preparacion de clatratos con ciclodextrinas de derivados de carbaciclina
ATE23716T1 (de) 5,6,7-trinor-4,8-inter-m-phenylen-prostaglandin i2-derivate.
DE3169305D1 (en) Carbacyclins, process for their preparation and their utilization as pharmaceutical preparations
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES482112A1 (es) Procedimiento de preparacion de nuevos derivados de 3,20- dioxo-4,9-dieno-21-hidroxilo-esteroides.
HK192696A (en) New alkanephenones
PH20454A (en) New carbacyclin compounds and pharmaceutical preparations containing same
ES8500953A1 (es) Procedimiento para preparar derivados de tieno-tiazol
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
EP0069049A3 (en) Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8401008A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES8402809A1 (es) Procedimiento para la preparacion de carbaciclinas.
ES8701749A1 (es) Un procedimiento para preparar nuevos derivados del 1,3-benzo-xatiol.
ZA85985B (en) Novel carbacyclins,process for the preparation thereof,and their use as medicinal agents
ES8405355A1 (es) Procedimiento para la preparacion de derivados de 5-fluorocarbaciclinas
HUT45475A (en) Process for producing 4-hydroxy-4-/substituted alkenyl/-cyclohexane carboxylic acid derivatives
ES8307838A1 (es) Procedimiento para la preparacion de 3-deshidro-cardenolido-tridigitoxosido-oximas.
DK573487A (da) Cyklodextrinclathrater af carbacyklinderivater og anvendelse deraf som laegemiddel

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070308